Conning Inc’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Conning Inc’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-50,000	Closed	-$1.36M	–	596
2018 Q1	$1.36M	Hold	50,000	–	–	0.04%	230
2017 Q4	$1.44M	Hold	50,000	–	–	0.05%	234
2017 Q3	$1.21M	Hold	50,000	–	–	0.04%	251
2017 Q2	$1.12M	Buy	+50,000	New	+$1.05M	0.04%	268

Other funds holding DOVA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Conning Inc's DOVA Position: Q2 2018 in Review

Conning Inc sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q2 2018, closing a stake of 50,000 shares — an estimated $1.36M sold.

Conning Inc first reported a position in DOVA in Q2 2017 and held it in 4 quarters. The position peaked at $1.44M in Q4 2017. 60 funds tracked by Wall St. Rank hold DOVA as of Q2 2018.

Conning Inc reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Conning Inc sold 50,000 Dova Pharmaceuticals, Inc. Common Stock shares in Q2 2018, an estimated $1.36M.
Conning Inc first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 4 quarters.
Conning Inc's Dova Pharmaceuticals, Inc. Common Stock position peaked at $1.44M in Q4 2017.
60 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q2 2018.

Based on Conning Inc's 13F filing for Q2 2018, filed 25 Jul 2018.